Chembond Material Technologies Limited (formerly Chembond Chemicals Limited) announced the outcome of its Board Meeting held on July 17, 2026. The meeting commenced at 12:15 PM and concluded at 3:55 PM.
Key Financial Figures - Consolidated Results (₹ in Lakhs)
- Revenue from operations: ₹7,241.56 (Q1 FY27) vs ₹5,767.50 (Q1 FY26) vs ₹7,175.37 (Q4 FY26)
- Other Income: ₹376.55 (Q1 FY27) vs ₹265.14 (Q1 FY26) vs (₹166.30) (Q4 FY26)
- Total Income: ₹7,618.11 (Q1 FY27) vs ₹6,032.64 (Q1 FY26) vs ₹7,009.07 (Q4 FY26)
- Profit Before Tax: ₹582.99 (Q1 FY27) vs ₹536.53 (Q1 FY26) vs ₹386.47 (Q4 FY26)
- Profit For the Period: ₹572.62 (Q1 FY27) vs ₹399.02 (Q1 FY26) vs ₹348.48 (Q4 FY26)
- Total Comprehensive Income: ₹578.30 (Q1 FY27) vs ₹400.05 (Q1 FY26) vs ₹370.37 (Q4 FY26)
- Basic EPS: ₹4.26 (Q1 FY27) vs ₹2.97 (Q1 FY26) vs ₹2.59 (Q4 FY26)
- Diluted EPS: ₹4.26 (Q1 FY27) vs ₹2.97 (Q1 FY26) vs ₹2.59 (Q4 FY26)
Key Financial Figures - Standalone Results (₹ in Lakhs)
- Revenue from operations: ₹6,296.89 (Q1 FY27) vs ₹4,892.03 (Q1 FY26) vs ₹6,008.05 (Q4 FY26)
- Profit Before Tax: ₹455.16 (Q1 FY27) vs ₹457.28 (Q1 FY26) vs ₹281.13 (Q4 FY26)
- Profit For the Period: ₹450.33 (Q1 FY27) vs ₹316.95 (Q1 FY26) vs ₹191.43 (Q4 FY26)
- Total Comprehensive Income: ₹455.23 (Q1 FY27) vs ₹318.31 (Q1 FY26) vs ₹209.19 (Q4 FY26)
- Basic EPS: ₹3.35 (Q1 FY27) vs ₹2.36 (Q1 FY26) vs ₹1.42 (Q4 FY26)
- Diluted EPS: ₹3.35 (Q1 FY27) vs ₹2.36 (Q1 FY26) vs ₹1.42 (Q4 FY26)
Business Segments Analysis
The Group operates in two reportable segments:
1. Specialty Chemical: Revenue of ₹6,205.48 lakhs with segment result of ₹100.88 lakhs
2. Animal Health: Revenue of ₹1,036.08 lakhs with segment result of ₹105.57 lakhs
Total segment results were ₹206.44 lakhs, with unallocable other income of ₹376.55 lakhs contributing to total profit before tax of ₹582.99 lakhs.
Subsidiary Information
The Group consolidates one subsidiary: Chembond Biosciences Limited. Segment assets totaled ₹22,203.55 lakhs and segment liabilities totaled ₹4,929.14 lakhs as of June 30, 2026.
Additional Information
The company has decided not to opt for the new tax structure under Section 200 of the Income Tax Act, 2025. The comparative figures for previous periods have been restated/regrouped for comparability. The financial results can be accessed on the company's website at www.chembond.in.
Audit Information
The limited review was conducted by M/s. Kastury & Talati Chartered Accountants (Firm Regn. No.: 104908W). The comparative figures for the corresponding quarter ended June 30, 2025, were reviewed by the predecessor auditor who expressed an unmodified conclusion.